spacer
home > pmps > autumn 2009 > anti-counterfeiting: a multi-layered approach
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Anti-Counterfeiting: A Multi-Layered Approach

 

When my parents joined our family on a vacation this spring, I asked my father about the medication he was taking each morning for high blood pressure. When I inquired, “Are you sure you have the real thing, not a fake?” he looked puzzled and shrugged his shoulders. Like most people, my father had never considered the possibility that his prescription medication could be counterfeit. Yet pharmaceutical counterfeiting is a growing global problem, affecting public health and the pharmaceutical industry.

The World Health Organization (WHO) estimates that up to 10 per cent of the world’s drug supply is counterfeit (1). This figure increases dramatically in developing countries that lack the resources to validate all their incoming drugs. US Immigration and Customs Enforcement (ICE) believes that the largest number of counterfeit products come from China and India, as well as south-east Asia, Nigeria, Russia, Mexico, Brazil and Latin America. Drug counterfeiting has become an industry worth more than €1 billion (2).

The National Association of Boards of Pharmacy (NABP) has identified 32 products at high risk of being counterfeited. My father’s drug is not among them, nor are countless other products that have already been affected by counterfeiting (3).

A counterfeit medicine, as defined by the WHO, “is one which is deliberately and fraudulently mislabelled with respect to identity, composition and/or source...Counterfeit products may include products with correct ingredients or with the wrong ingredients, without active ingredients, with insufficient active ingredients or with fake packaging” (4).

Trends in Brand Security

Today, pharmaceutical companies are placing far more emphasis than ever before on packaging and security features for brand safety, particularly for their most popular brands. They dedicate teams to find qualified pharmaceutical packaging printers who can help them stay informed of the latest developments in this arena, determine which security features the company should adopt, and incorporate them into their products.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Eric Caro is Global Product Manager for Catalent’s Printed Components Business. Eric provides technical support to the plant and sales team on labels and inserts, and drives new and existing projects through the organisation to increase speed to market. He is also responsible for analysing customer and business needs to determine what equipment, tooling or delivery systems to introduce to the market and for providing engineering support to the sales team and customers. Prior to joining Catalent, he was a Research and Development Manager, as well as a Senior Account Executive for Cortegra. Prior to that, Eric was an Account Manager for Prime Graphics, and also an Account Manager at Pechiney Plastic Packaging at Alcan. Eric has many years of technical experience in the healthcare packaging industry. He holds a BSc in Mechanical Engineering Technology from the Rochester Institute of Technology.
spacer
Eric Caro
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma Celebrates 15 Years of Growth and Success

Vilnius, Lithuania, July 16, 2019 ─ Northway Biotechpharma, a leading biopharmaceutical contract development and manufacturing organization (CDMO), celebrates its 15th anniversary today. As a midsized CDMO, Northway Biotechpharma is able to provide flexibility and responsiveness backed by a strong foundation in science and technology. The company focuses on understanding its customers and meeting their specific needs without binding them to one single approach. It is able to react rapidly to unexpected project changes, adjusting timelines, capacities and other activities to meet its customers’ evolving needs. On average, Northway Biotechpharma has 25–30 development projects underway each year, ranging from gene cloning to final drug product manufacturing.
More info >>

White Papers

The Importance of Critical Temperatures in the Freeze Drying of Pharmaceutical Products

Biopharma Group

Every formulation has a critical temperature, below which it should be cooled for complete solidification and maintained below during primary drying in order to prevent processing defects. To design a freeze drying cycle on a rational basis such information should be identified.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement